Stockreport

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

Dogwood Therapeutics, Inc.  (DWTX) 
PDF - Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex P [Read more]